Aurinia (AUPH) | Stock Overview & Key Data

What is AUPH's 52-week high and low?

In the last 52 weeks, Aurinia reached a high of $10.67 (on December 10, 2024) and a low of $5.20 (on August 6, 2024).

What is the market cap and P/E ratio for AUPH?

Curious about Aurinia's size and valuation? Its market capitalization stands at 1.06B. When it comes to valuation, the P/E ratio (trailing twelve months) is 29.00, and the forward P/E (looking ahead) is 14.50.

Does AUPH pay dividends? If so, what's the yield?

As for dividends, Aurinia isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Aurinia's main competitors or similar companies to consider before investing?

When looking at Aurinia, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	114.06B	Healthcare	Biotechnology	-3.15%	56.18%
Regeneron REGN	55.27B	Healthcare	Biotechnology	-47.08%	-11.94%
Vera Therapeutics VERA	1.38B	Healthcare	Biotechnology	-32.64%	63.38%
Immunocore Holdings IMCR	1.56B	Healthcare	Biotechnology	-10.68%	-26.05%
Agios AGIO	1.93B	Healthcare	Biotechnology	-15.43%	38.73%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Aurinia Pharmaceuticals Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Aurinia's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.23%, the Debt to Equity ratio from the most recent quarter is 22.25, and its Gross Profit Margin stands at 86.27%.

What is the recent revenue and earnings growth for AUPH?

Looking at Aurinia's growth, its revenue over the trailing twelve months (TTM) was $247M. Compared to the same quarter last year (YoY), quarterly revenue grew by 24.20%, and quarterly earnings saw a YoY growth of 24.18%.

How much of AUPH stock is held by insiders and institutions?

Wondering who owns Aurinia stock? Company insiders (like executives and directors) hold about 9.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 47.38%.

For more common questions about our data, please visit our About Data page.